Biotech

Stemina Biomarker Discovery will receive $212,500 as part of a round of stock financing directed by DaneVest Tech Fund I. Stemina Biomarker, co-founded by University of Wisconsin-Madison researcher Gabriela Cezar and former Wisconsin Alumni Research Foundation counsel Beth Donley, is commercializing a proprietary metabolomics technology...

Is the American pharma industry going the way of the U.S. auto industry? Given what transpired in 2007, columnist Michael Rosen wonders about that in this edition of Yer Biotech Blues. The way Big Pharma has and likely will continue to scamble to recover lost...

Deltanoid Pharmaceuticals, a privately held pharmaceutical development company spun out of the University of Wisconsin-Madison, has announced the completion of a $12 million round of financing that will be used to advance therapies for the treatment of renal disease. The money comes from a group...

Third Wave Technologies, a Madison-based research molecular diagnostics company, has received a $25 million line of credit from Deerfield Management. The additional capital will support the execution of long-range plans for the human papilloma virus and the hospital lab markets. ...

The high cost of developing prescription drugs has started a race to make pharmaceutical products more affordable, and venture capitalists are placing bets on the outcome. CDI Bioscience, a Madison-based company that has developed a technology to boost protein production and lower drug-manufacturing costs, will...

UW-Madison Chancellor John D. Wiley, who has led Wisconsin's flagship university since 2001, has announced that he is stepping down as chancellor effective in September of 2008. Under Wiley's leadership, UW-Madison has risen to No. 2 nationally in terms of the amount of research conducted...

New distribution agreements signed by TomoTherapy will extend access to the company's cancer treatment technology to a greater percentage of the global marketplace. TomoTherapy has signed contracts with distributors in Israel, Greece, Poland, Turkey, Russia, and the United Arab Emirates. ...

A team led by University of Wisconsin biologist Gabriela Cezar has used human embryonic stem cells to predict the toxic effects of drugs and provide chemical clues to diagnosing disease, according to a report in the journal Stem Cells and Development. By tuning in to...

ConjuGon has been awarded $1.2 million from the U.S. Department of Defense in 2008 to help fund the development of a new wound infection treatment product. The funds are included in the fiscal year 2008 defense appropriations bill, which was signed into law by President...